These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC. BMC Infect Dis; 2015 Feb 15; 15():62. PubMed ID: 25888317 [Abstract] [Full Text] [Related]
25. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique. Floridia M, Ciccacci F, Andreotti M, Hassane A, Sidumo Z, Magid NA, Sotomane H, David M, Mutemba E, Cebola J, Mugunhe RJ, Riccardi F, Marazzi MC, Giuliano M, Palombi L, Mancinelli S. Clin Infect Dis; 2017 Nov 13; 65(11):1878-1883. PubMed ID: 29020319 [Abstract] [Full Text] [Related]
28. Urinary lipoarabinomannan in individuals with sputum-negative pulmonary tuberculosis. Ajantha P, Puri MM, Tayal D, Khalid U. Indian J Med Res; 2024 Feb 01; 159(2):206-212. PubMed ID: 38577859 [Abstract] [Full Text] [Related]
30. Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease. Drain PK, Niu X, Shapiro AE, Magcaba ZP, Ngcobo Z, Ngwane MW, Thomas KK, Dalmat RR, Morton JF, Budiawan E, Pinter A, Cantera J, Anderson C, Buchmann R, Wilson D, Grant B, Prove-TB Study team. EBioMedicine; 2024 Oct 01; 108():105353. PubMed ID: 39332390 [Abstract] [Full Text] [Related]
33. Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis. Kerkhoff AD, Wood R, Vogt M, Lawn SD. PLoS One; 2014 Oct 01; 9(7):e103285. PubMed ID: 25075867 [Abstract] [Full Text] [Related]
34. Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria. Wood R, Racow K, Bekker LG, Middelkoop K, Vogt M, Kreiswirth BN, Lawn SD. BMC Infect Dis; 2012 Feb 27; 12():47. PubMed ID: 22369353 [Abstract] [Full Text] [Related]
35. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R, TB IRIS Group. J Acquir Immune Defic Syndr; 2011 Dec 15; 58(5):463-8. PubMed ID: 21963941 [Abstract] [Full Text] [Related]
36. Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients. Peter JG, Cashmore TJ, Meldau R, Theron G, van Zyl-Smit R, Dheda K. Int J Tuberc Lung Dis; 2012 Aug 15; 16(8):1108-12. PubMed ID: 22710609 [Abstract] [Full Text] [Related]
37. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. d'Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E. Pan Afr Med J; 2015 Aug 15; 22():4. PubMed ID: 26600904 [Abstract] [Full Text] [Related]
38. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. Tessema TA, Bjune G, Hamasur B, Svenson S, Syre H, Bjorvatn B. Scand J Infect Dis; 2002 Aug 15; 34(2):97-103. PubMed ID: 11928861 [Abstract] [Full Text] [Related]
39. Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer? Sabur NF, Esmail A, Brar MS, Dheda K. BMC Infect Dis; 2017 Dec 28; 17(1):803. PubMed ID: 29282005 [Abstract] [Full Text] [Related]